Here, our results showed that p53 regulated miR-29c at transcriptional level by binding to its promoter, and that IGF2 secreted by ESCC cells may downregulate p53 by activating AKT/MDM2, thereby increasing VEGF expression in fibroblasts (Fig. 4). The gene discussed is TP53; the disease is esophageal squamous cell carcinoma.